MC Dalakas, M Fujii, M Li, B Lutfi, J Kyhos, B … - New England Journal …, 2001 - content.nejm.org Results Among patients who received immune globulin first, stiffness scores decreased significantly
(P=0.02) and heightened-sensitivity scores decreased substantially during immune globulin
therapy but rebounded during placebo administration. In contrast, the scores in the group ... Cited by 130 - Related articles - BL Direct - All 7 versions
- ►aaaai.org [PDF] JS Orange, EM Hossny, CR Weiler, M Ballow, M … - The Journal of Allergy and …, 2006 - Elsevier Over the past 2½ decades, administration of exogenous pooled human immunoglobulin for intravenous
use (IGIV; commonly referred to as IVIG, although licensed in the United States as IGIV) has become
an important therapy in clinical medicine. The original use of these immunoglobulin ... Cited by 100 - Related articles - All 28 versions
MC Dalakas, M Li, M Fujii, DM Jacobowitz - Neurology, 2001 - AAN Enterprises Methods: — The authors studied 18 patients with SPS and positive serum immunoreactivity to
gamma-aminobutyric acid (GABA)-ergic neurons. The reactivity of serum and CSF to purified
GAD antigen was examined by Western blots, and the anti-GAD 65 antibody titers in ... Cited by 77 - Related articles - BL Direct - All 3 versions
LM Levy, M Hallett - Annals of neurology, 2002 - interscience.wiley.com Patients with task-specific dystonia (writer's cramp) have impaired cortical inhibition likely arising
from striatal dysfunction. However, the levels of the inhibitory neurotransmitter gamma-aminobutyric
acid (GABA) in the brains of these patients are not known. In this study, we evaluated 7 ... Cited by 66 - Related articles - BL Direct - All 3 versions
MC Dalakas, M Fujii, M Li, B McElroy - Neurology, 2000 - AAN Enterprises Address correspondence and reprint requests to Dr. Marinos C. Dalakas, Neuromuscular Diseases
Section, NINDS, National Institutes of Health, Building 10, Room 4N248, 10 Center Drive MSC
1382, Bethesda, MD 20892-1382. ... OBJECTIVE: To evaluate the clinical spectrum of ... Cited by 66 - Related articles - BL Direct - All 3 versions
LM Levy, U Ziemann, R Chen, LG Cohen - Annals of neurology, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 44 - Related articles - BL Direct - All 3 versions
- ►jimmunol.org R Raju, J Foote, JP Banga, TR Hall, CJ … - The Journal of …, 2005 - Am Assoc Immnol Autoantibodies to the 65-kDa isoform of glutamate decarboxylase GAD65 (GAD65Ab) are strong
candidates for a pathological role in Stiff-Person syndrome (SPS). We have analyzed the binding
specificity of the GAD65Ab in serum and cerebrospinal fluid (CSF) of 12 patients with SPS ... Cited by 34 - Related articles - BL Direct - All 5 versions
OM Vasconcelos, MC Dalakas - Current Treatment Options in Neurology, 2003 - Springer CLINICAL SYMPTOMOLOGY Stiff-man syndrome (SMS) was a term coined by Moersh and Woltman
[1] to describe a series of 14 patients, who presented with progressive and fluctuating muscle
stiffness, painful muscle spasms, and difficulties with ambulation, collected over many ... Cited by 30 - Related articles - BL Direct - All 2 versions
G Rakocevic, R Raju, MC Dalakas - Archives of Neurology, 2004 - archneur.highwire.org Background Stiff-person syndrome (SPS) is an immune-mediated central nervous system disorder
characterized by fluctuating muscle stiffness, disabling spasms, and heightened sensitivity to
external stimuli. Up to 80% of patients with SPS have anti–glutamic acid decarboxylase ( ... Cited by 30 - Related articles - BL Direct - All 4 versions
BB Murinson - The Neurologist, 2004 - journals.lww.com Perhaps the two most significant advances in charac- terizing SPS are the development of a
precise clinical char- acterization of the disorder and the identification of disease associated
antibodies. SPS was initially identified by Moer- sch and Woltman in 1956.1 This report is ... Cited by 27 - Related articles - BL Direct - All 2 versions
